About Marianna Limas

This author has not yet filled in any details.
So far Marianna Limas has created 28 blog entries.

Intellia Therapeutics Announces Proposed Public Offering of Common Stock

Nov 1, 2017 CAMBRIDGE, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq:NTLA), a leading genome editing company focused on the development of potentially curative therapeutics using CRISPR/Cas9 technology, today announced that it has commenced an underwritten public offering of $150 million of [...]

By | November 1st, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Learning from Nature to Develop new Organisms that Replace Technology with Biology

This week we interviewed Jason Kelly, CEO and Co-Founder of Ginkgo Bioworks, who will be giving a keynote talk at SynBioBeta SF 2017 on October 3rd. Ginkgo recently announced the creation of a new company with Bayer, with a $100M [...]

By | September 28th, 2017|Agriculture, News|

Synthetic Biology and Immunotherapy to Bring More Effective Cell Therapies for Cancer

For years, the foundations of cancer treatment were chemotherapy, surgery, and radiation therapy. But over the past several years, progress with therapies that collect and use a patient’s own immune cells to attack tumors (in other words, immunotherapy) have greatly [...]

By | September 22nd, 2017|BioPharma & Healthcare, News, Therapeutics|

Meet Laura Adam, an Expert in Design Automation in Synthetic Biology

This week we interviewed Laura Adam, who will be speaking in the Computation and Synthetic Biology session (Sponsored by Amazon Web Services) at SynBioBeta SF 2017. She is an expert in the field of synthetic biology design automation and has [...]

By | September 22nd, 2017|CAD Tools, Industry Providers, News|

A New Enzymatic Approach to DNA Synthesis Could be the Next Breakthrough in Synthetic Biology

The Molecular Assemblies story began more than 30 years ago when Dr. J. William Efcavitch and Curt Becker recognized the limitations of the chemical-based method of DNA synthesis.  The process relies on harsh chemicals that both damage the DNA and [...]

By | September 21st, 2017|DNA Synthesis, Industry Providers, News|

New Bioinspired Materials: Why AMSilk is Betting on Bioengineered Silk Polymers

Scientists have tried to mass-produce spider silk for decades with little success. As a naturally occurring supermaterial, spider silk is strong, extendible, lightweight, biodegradable, flexible, biocompatible, and can be processed into different formats, including 3D structures. Unlocking the secret to [...]

By | September 21st, 2017|Biomaterials, Consumer Products & Manufacturing, News|
tadalafiltablets findviagra.com http://xanaxonlinebuy.com/